Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.

Saved in:
Bibliographic Details
Title: Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Authors: Finley RS, Fortner CL, deJongh CA, Wade JC, Newman KA, Caplan E, Britten J, Wiernik PH, Schimpff SC
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 1982 Aug; Vol. 22 (2), pp. 193-7.
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print Cited Medium: Print ISSN: 0066-4804 (Print) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0066-4804
DOI:10.1128/AAC.22.2.193